Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doliba, N. M.
Right arrow Articles by Matschinsky, F. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doliba, N. M.
Right arrow Articles by Matschinsky, F. M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 52:394-402, 2003
© 2003 by the American Diabetes Association, Inc.

Differential Effects of Glucose and Glyburide on Energetics and Na+ Levels of ßHC9 Cells

Nuclear Magnetic Resonance Spectroscopy and Respirometry Studies

Nicolai M. Doliba1, Marko Z. Vatamaniuk1, Carol W. Buettger1, Wei Qin1, Heather W. Collins1, Suzanne L. Wehrli2, Richard D. Carr3, and Franz M. Matschinsky1

1 Diabetes Research Center and Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
2 Division of Metabolism, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
3 Pharmacological Research 1, Novo Nordisk, Bagsvaerd, Denmark

In the present study, noninvasive 31P and 23Na+–nuclear magnetic resonance (NMR) technology and respirometry were used to compare the effect of high glucose (30 mmol/l) with the effect of the antidiabetic sulfonylurea (SU) compound glyburide (GLY) on energy metabolism, Na+ flux, insulin, and cAMP release of continuously superfused ß-HC9 cells encapsulated in microscopic agarose beads. Both high glucose and GLY increased oxygen consumption in ß-HC9 cells (15–30%) with a maximal effect at 8 mmol/l for glucose and at 250 nmol/l for GLY. At the same time, insulin release from ß-cells increased by 15- and 25-fold with high glucose or GLY, respectively. The P-creatine (PCr) level was greatly increased and inorganic phosphate (Pi) was decreased with 30 mmol/l glucose in contrast to the decreased level of PCr and increased Pi with GLY. ATP levels remained unchanged during both interventions. Studies on isolated mitochondria of ß-HC9 cells showed that GLY added to mitochondria oxidizing glutamine or glutamate abolished the stimulation of respiration by ADP (state 3) meanwhile leaving state 3 respiration unchanged during oxidation of other substrates. Exposure of ß-HC9 cells to 5 mmol/l glucose decreased intracellular Na+ levels monitored by 23Na+-NMR spectroscopy and 30 mmol/l glucose resulted in a further decrease in cytosolic Na+. In contrast, Na+ increased when 1 µmol/l GLY was added to the perfusate containing 5 mmol/l glucose. These data support the hypothesis that glucose activates the ß-cell through a "push mechanism" due to substrate pressure enhancing fuel flux, energy production, and extrusion of Na+ from the cells in contrast to SU receptor (SUR)-1 inhibitors, which may modify intermediary and energy metabolism secondarily through a "pull mechanism" due to higher energy demand resulting from increased ion fluxes and the exocytotic work load.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. M. Doliba, S. L. Wehrli, M. Z. Vatamaniuk, W. Qin, C. W. Buettger, H. W. Collins, and F. M. Matschinsky
Metabolic and ionic coupling factors in amino acid-stimulated insulin release in pancreatic beta-HC9 cells
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1507 - E1519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. E. Fridlyand, L. Ma, and L. H. Philipson
Adenine nucleotide regulation in pancreatic {beta}-cells: modeling of ATP/ADP-Ca2+ interactions
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E839 - E848.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Tarasov, J. Dusonchet, and F. Ashcroft
Metabolic Regulation of the Pancreatic Beta-Cell ATP-Sensitive K+ Channel: A Pas de Deux
Diabetes, December 1, 2004; 53(suppl_3): S113 - S122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Li, C. Buettger, J. Kwagh, A. Matter, Y. Daikhin, I. B. Nissim, H. W. Collins, M. Yudkoff, C. A. Stanley, and F. M. Matschinsky
A Signaling Role of Glutamine in Insulin Secretion
J. Biol. Chem., April 2, 2004; 279(14): 13393 - 13401.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. R. Sweet, D. L. Cook, E. DeJulio, A. R. Wallen, G. Khalil, J. Callis, and J. Reems
Regulation of ATP/ADP in Pancreatic Islets
Diabetes, February 1, 2004; 53(2): 401 - 409.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.